Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Ono Pharma Announces Upcoming Presentations at the ASCO 2026 Annual Meeting

businesswire.com
BMY

THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION

prnewswire.com
ABBV JNJ ARQT BMY LLY INCY SNY REGN PFE UCB BIIB ORGN TAK ELMD

Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda

globenewswire.com
MRK BMY GILD TAK

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

globenewswire.com
JNJ AMGN GMAB ABBV AZN PFE BMY REGN XNCR ZYME

Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications

globenewswire.com
ACIU AZN BMY

Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights

globenewswire.com
MRK BMY AMGN REPL

Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge

globenewswire.com
AZN MRK BMY PFE AMGN

Immune Checkpoint Inhibitors Market Report 2026-2030 with Detailed Company Profiles, Grant Analyses, Partnership Evaluations and More

globenewswire.com
BMY GSK INCY NVS

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

globenewswire.com
ARDX BMY

U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV

globenewswire.com
MRK PFE JNJ BMY GILD LLY AMGN REGN ABBV BIIB